HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clash Of The Power Toothbrush Titans: P&G Challenges Philips' Sonicare Claims, Both Firms Appeal NAD Decision

This article was originally published in The Rose Sheet

Executive Summary

Following its review of the two firms' latest clash over power brush claims, Council of Better Business Bureau's investigative division says Philips and P&G are appealing its recommendations within the industry self-regulation process.The recommendations were from a review conducted on the second challenge P&G made in a year on Philips' ads comparing the two firms' product.

You may also be interested in...

P&G Prevails In NAD Case Versus Philips’ Sonic Toothbrush Claims

The National Advertising Division recommends that Philips Oral Healthcare discontinue a handful of claims for Sonicare FlexCare and FlexCare+, including statements suggesting that its power toothbrushes outperform Procter & Gamble’s Oral-B Triumph 9000.

P&G SpinBrush Sale Expected To Facilitate FTC Gillette Deal Approval

Procter & Gamble has entered into a definitive agreement to sell its U.S. SpinBrush toothbrush business to Church & Dwight in an effort to ensure Federal Trade Commission approval of its Gillette acquisition

P&G $57 Bil. Gillette Acquisition Creates 21 Billion-Dollar Brand Portfolio

Procter & Gamble will acquire Gillette in a stock transaction valued at $57 bil., creating a consumer products powerhouse with combined sales of over $60 bil. and a portfolio that includes 21 billion-dollar brands, the two firms announced at a news conference in New York City Jan. 28

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts